The mission of the MDRC is to promote new discoveries and enhance scientific progress through the support of cutting-edge basic and clinical research by its highly interactive research base. The MDRC research base comprises 145 members: 118 members with $56.8 million of annual direct cost diabetes-related funding at the University of Michigan (UM) along with 27 regional members with $8.6 million of annual funding at three nearby Regional Partner Institutions: Michigan State University (MSU), Wayne State University (WSU) and the University of Toledo (UT). The investigators that make up the MDRC research base perform ground-breaking research in five broad areas relevant to diabetes: Cellular Aspects of Diabetes and Metabolism; Integrative Aspects of Diabetes and Metabolism; Islet Biology; Diabetic Complications; and Clinical Research in Diabetes and Metabolism. To support and empower research by its members, the MDRC will: 1. Coordinate activities that raise awareness of, interest in, and support for basic and translational research in diabetes, its complications, and related endocrine and metabolic disorders at the University of Michigan and beyond. 2. Advance learning and promote scientific exchange related to diabetes, endocrinology and metabolism. 3. Provide research cores that provide shared, specialized technical resources and expertise that enhance the efficiency, productivity, and multidisciplinary nature of research performed by MDRC investigators. 4. Support a Pilot and Feasibility studies grant program. 5. Provide support for research in diabetes, its complications, and related endocrine and metabolic disorders at Regional Partner Institutions. The MDRC provides membership, enrichment activities, an expanded Pilot and Feasibility Grant Program, and access to the MDRC Molecular Genetics Core for researchers at Regional Partner Institutions who study diabetes, its complications, and related endocrine and metabolic disorders.
? MDRC Center Overview The MDRC oversees and provides research cores, enrichment activities and pilot and feasibility grants programs to promote new discoveries and enhance scientific progress through the support of cutting-edge basic and clinical research by its highly interactive research base, which comprises 145 members at the University of Michigan and regional partner institutions (Michigan State University (MSU), Wayne State University (WSU) and the University of Toledo (UT).
|Larkin, Daniel F P (2018) Letter to the Editor in Response to Kim et al, ""Effect of Histocompatibility Y Antigen Matching on Graft Survival in Primary Penetrating Keratoplasty."" Cornea 37:e29|
|Peck, Bailey C E; Seeley, Randy J (2018) How does 'metabolic surgery' work its magic? New evidence for gut microbiota. Curr Opin Endocrinol Diabetes Obes 25:81-86|
|Mitok, Kelly A; Freiberger, Elyse C; Schueler, Kathryn L et al. (2018) Islet proteomics reveals genetic variation in dopamine production resulting in altered insulin secretion. J Biol Chem 293:5860-5877|
|Rupp, Alan C; Allison, Margaret B; Jones, Justin C et al. (2018) Specific subpopulations of hypothalamic leptin receptor-expressing neurons mediate the effects of early developmental leptin receptor deletion on energy balance. Mol Metab :|
|Akama, Takeshi; Chun, Tae-Hwa (2018) Transcription factor 21 (TCF21) promotes proinflammatory interleukin 6 expression and extracellular matrix remodeling in visceral adipose stem cells. J Biol Chem 293:6603-6610|
|Peyrot, Mark; Dreon, Darlene; Zraick, Vivien et al. (2018) Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch. Diabetes Ther 9:297-307|
|Guo, Huan; Sun, Jinhong; Li, Xin et al. (2018) Positive charge in the n-region of the signal peptide contributes to efficient post-translational translocation of small secretory preproteins. J Biol Chem 293:1899-1907|
|Flannick, Jason (see original citation for additional authors) (2018) Erratum: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls. Sci Data 5:180002|
|Huang, Chao; Fisher, Kiera P; Hammer, Sandra S et al. (2018) Plasma Exosomes Contribute to Microvascular Damage in Diabetic Retinopathy by Activating the Classical Complement Pathway. Diabetes 67:1639-1649|
|Ge, C; Mohamed, F; Binrayes, A et al. (2018) Selective Role of Discoidin Domain Receptor 2 in Murine Temporomandibular Joint Development and Aging. J Dent Res 97:321-328|
Showing the most recent 10 out of 1823 publications